News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat, page-143

That is not what I said so don't misquote me please.

Biden will sharpen up the practices of disclosure of conflict of interest and governance issues.
There is NO WAY that you should have decision makers on the bodies who have an interest in the company that is bringing the trial results for analysis.
AND have fast tracked America First bs which pumps pharmaceutical drug companies with opportunities, without regard for optimal patient outcomes.
Yes, lives have been saved but it's a suboptimal result. I get tired of explaining this over and over again.

funnily enough @optimistus told me he had an interest in governance yet he has had absolutely zero interest in these points in relation to the FDA.
He ran the bizarre line that MSB had governance problems. Those were the days!